PTC Therapeutics Inc (PTCT) Stock Analysis

PTC Therapeutics Inc (PTCT) is a publicly traded company in the HEALTHCARE sector. It trades at $68.23, carries a market capitalization of $6.12B. This page summarizes the public market data, fundamentals, and frequently asked questions for PTCT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

PTC Therapeutics Inc currently has a Bullish sentiment score of 0.37.

About PTC Therapeutics Inc

PTC Therapeutics, Inc. is a pioneering biopharmaceutical firm based in South Plainfield, New Jersey, dedicated to creating innovative therapies for rare genetic disorders. Leveraging its expertise in RNA modulation and small molecule therapeutics, PTC has developed a robust pipeline of advanced product candidates aimed at addressing significant unmet medical needs. The company's strategic focus on transformative treatments positions it as a key player in the rare disease space, driving advanc...

GNG Research Analysis

GNG Research scores PTC Therapeutics Inc (PTCT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PTCT.

Frequently Asked Questions

Does PTCT pay dividends?

PTC Therapeutics Inc (PTCT) does not currently pay a regular dividend.

What is PTCT's market cap?

PTC Therapeutics Inc (PTCT) has a market capitalization of $6.12B with a current stock price of $68.23.